Health coaching
Our research shows that you can lose up to 50% more weight when combining health coaching than using medication alone.
What is Wegovy?
Wegovy is a prescription weight loss treatment that contains the active ingredient semaglutide, belonging to a group of medications called GLP-1 inhibitors.¹
It works by mimicking a naturally occurring hormone in the body called GLP-1, stimulating nerve receptors in the brain that control appetite, so you feel less hungry and have fewer cravings.¹
Additionally, it stimulates the release of insulin from pancreatic beta cells, as GLP-1 is present in both the pancreas and the brain.³ Implementing behavioural change strategies alongside the treatment is known to be an effective method for weight loss.2
How does Wegovy work?
Wegovy contains the active ingredient semaglutide, which mimics a natural hormone that suppresses your appetite and reduces food cravings.2
Clinical trials have proven that the drug drives healthier choices that lead to weight loss. These include:2,3
Reduces appetite
Reduces cravings
Non-addictive
Easy to administer
Reduces risk of cardiovascular disease
Who is eligible for Wegovy?
Wegovy is suitable for people struggling with weight management who meet specific criteria. To be eligible, you need to have a BMI of 30 or more, or over 27 if you have a weight-related condition like high blood pressure, cardiovascular disease, or type 2 diabetes. It should only be taken alongside making lifestyle and dietary changes.4
It’s designed for those who have already tried traditional weight loss methods without success and are ready for a new approach to achieving their health goals.4
To be considered for Wegovy, you’ll need to complete an online questionnaire that gathers key information about your health and weight management journey.4 Following this, you’ll have a consultation with a Numan clinician who will assess your eligibility based their clinical judgement and your medical history.
How effective is Wegovy?
In a major clinical trial, participants who received the full therapeutic dose of 2.4 mg per week lost an average of 15% of their body weight over 68 weeks, compared to just 2.4% in those who received a placebo. This level of weight loss is significantly greater than what’s typically seen with lifestyle changes alone.1
The study found a clear dose-response relationship, whereby lower doses of semaglutide (such as 1.0 mg or 1.7 mg) led to less weight loss, while the 2.4 mg dose produced the most substantial effects.1
Why choose Numan for Wegovy?
Numan isn't just an online pharmacy. We’re a holistic health provider offering complete care to help you get the most from your treatment. When you choose Wegovy with Numan, you’ll also get access to:
Wegovy treatments
Wegovy is gradually introduced to your body through a process called dose titration. This means that your dose is increased step by step over several months to allow your body to adjust to the medication and to help minimise side effects.
It's important to note that not everyone will need the highest dose to maintain, and that your maintenance dose will depend on how you respond to treatment.
Wegovy treatment doses are as follows:5
| Dose | Use |
|---|---|
| 0.25mg | Injected into the upper (subcutaneous) layer of the skin once a week. Dose is then titrated based on individual response. |
| 0.5mg | Injected into the upper (subcutaneous) layer of the skin once a week. Dose is then titrated based on individual response. |
| 1mg | Injected into the upper (subcutaneous) layer of the skin once a week. Dose is then titrated based on individual response. |
| 1.7mg | Injected into the upper (subcutaneous) layer of the skin once a week. Dose is then titrated based on individual response. |
| 2.4mg | Injected into the upper (subcutaneous) layer of the skin once a week. Dose is then titrated based on individual response. |
Wegovy doses
0.25mg
Starting dose
0.5mg
Second dose, often prescribed after 4-6 weeks
1 - 2.4mg
Possible maintenance doses
How to take Wegovy
Taking Wegovy is straightforward with the right guidance. It comes as a pre-filled injection pen that you use once a week.
To take Wegovy, you first prepare (prime) the pen, choose an injection site - like your stomach or thigh - and inject the dose following the instructions. Dispose of the needle safely in the yellow sharps bin, and store your pen with the cap on until the next use.
Important things to consider about Wegovy
Wegovy has a shelf life of 3 years when stored in the refrigerator before first use (2°C to 8°C), away from the cooling element. Do not freeze the pen, and never use it if it has been frozen.5
Once you start using a Wegovy pen, it can be kept for up to 6 weeks. During this time, you can store it below 30°C, though storing it in the fridge is preferred. Always keep the pen cap on when not in use to protect the medication from light.5
Most side effects from Wegovy are mild and temporary, especially during the first few weeks as your body adjusts to the medication and dose. The most common effects include nausea, diarrhoea, stomach cramps, bloating, and belching. Some people may also feel tired or dizzy.5
These symptoms usually settle as treatment continues.5 For a full list of possible side effects, always check the Patient Information Leaflet provided with your medication.
The duration of Wegovy treatment depends on individual health goals and response to the medication. Implementing lifestyle changes alongside the treatment is crucial for sustained weight management. By building healthier habits you should be able to sustain your weight beyond taking the medication. Your healthcare provider will guide you on the appropriate duration based on your progress and overall health.1-3
The difference between Mounjaro and Wegovy
It can be difficult to choose the right weight loss medication. However, a consultation with a Numan clinician can help you make a more informed decision. Below is a short summary of what the main differences are between Mounjaro and Wegovy.1,6
| Mounjaro | Wegovy | |
|---|---|---|
| Achievable weight loss, according to research | Up to 22.5% | Up to 18% |
| Protects against heart disease | No | Yes |
| Dosage | One weekly injection | One weekly injection |
Meet the experts
Numan’s Weight Loss Programme is developed by a team of specialists who understand the complex challenges of weight management. Drawing on the latest in metabolic research, appetite regulation, and behavioural science, our experts bring together innovative treatments and personalised strategies designed for sustainable results.
Our approach includes the use of Wegovy, a GLP-1 receptor agonist, which curbs cravings, making it easier to stay on track.1 Paired with guidance from healthcare professionals and lifestyle coaches, the programme adapts to your unique needs at every step.
Dr Luke Pratsides
Head of Medical
MBBS MSc MRCGP MFCI
Sophie Kanani
Health Coaching Operations Manager
BSc (Hons) Dip
Jess Uffindell
Registered Nutritionist
BANT CNHC BSc (Hons)
Mo Dekmak
Clinician
MPHARM PGDIP IPRESC
Shivani Sharma-Savani
Prescribing Lead
MPharm PGCert PCert IP
Faye Townsend
Senior Health Coach
AfN BSc BDA PGDIP BPS
OTHER SOLUTIONS
Effective treatments for weight loss
Proven solutions to change your weight, mindset, and behaviours.
Personalised health coaching
Health coaching is at the heart of our programme, designed to create lasting lifestyle changes. Paired with Wegovy’s appetite-regulating effects, our coaches provide guidance on building practical, sustainable habits in nutrition, exercise, sleep, and mindset.
Wegovy helps manage cravings, while our coaches enhance these benefits, offering advice on balanced meals, enjoyable movement, and effective routines for better health. Together, they give you the support needed to make meaningful progress and maximise your results.
/ "wl-app-")
Obesity: fighting the disease with effective treatment
Numan’s Weight Loss Programme tackles obesity with a fresh perspective, understanding it as a medical condition shaped by external factors.7 Our approach goes beyond conventional advice, incorporating treatments to provide a solid foundation for lasting lifestyle adjustments.
With obesity impacting a significant portion of the UK population, we offer a comprehensive solution that combines medical support with tailored guidance. By addressing the core drivers of weight gain, our programme empowers you to achieve and sustain a healthier weight with expert-led, compassionate care.
I feel I can live a longer, happier life with less risk of cardiovascular issues. I've struggled with being overweight for many years, so the impact has been life-changing.
I discovered an old bag of clothes and couldn’t believe how many of them fit me where I would have had no chance before. I feel amazing. I think I look much better than I ever did.
I want to be in good shape to enjoy life. But be happy as I’m doing it, rather than miserable. And I think I’ve managed that with the programme.
FAQS
Your questions answered
Medically reviewed by Hassan Thwaini
Clinical Pharmacist and Copywriter, Master of Pharmacy (MPharm)
KNOWLEDGE
Weight loss: what you need to know
References
1 News details. Novo Nordisk. https://www.novonordisk.com/news-and-media/news-and-ir-materials/news-details.html?id=62112 [Accessed 12th June 2025].
2 Garvey WT, Batterham RL, Bhatta M, Buscemi S, Christensen LN, Frias JP, et al. Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature medicine. 2022;28(10): 2083–2091.
3 Lincoff AM, Brown-Frandsen K, Colhoun HM, Deanfield J, Emerson SS, Esbjerg S, et al. Semaglutide and cardiovascular outcomes in obesity without diabetes. The New England journal of medicine. 2023;389(24): 2221–2232.
4 Overview | Semaglutide for managing overweight and obesity | Guidance | NICE. https://www.nice.org.uk/guidance/ta875
5 Wegovy 0.25 mg, FlexTouch solution for injection in pre-filled pen. Org.uk. https://www.medicines.org.uk/emc/product/13799/smpc [Accessed 12th May 2025].
6 Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, et al. Tirzepatide once weekly for the treatment of obesity. The New England journal of medicine. 2022;387(3): 205–216.
7 Lee A, Cardel M, Donahoo WT. Social and Environmental Factors Influencing Obesity. [Updated 2019 Oct 12]. In: Feingold KR, Anawalt B, Blackman MR, et al., editors. Endotext. South Dartmouth (MA): MDText.com, Inc.; 2000-.
Start your treatment journey
Answer a few simple questions to get the treatment you need.